leisure time
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: Amylyx's ALS drug launch starts strong. It could be trouble for FDA
Next article: Amylyx's ALS drug launch starts strong. It could be trouble for FDA
focus
hotspot
-
Wegovy trial has doctors encouraged over new possibilities
2025-09-06 04:08 -
In same hospitals, Black patients receive fewer opioids than white patients
2025-09-06 04:02 -
Maui's cultural, historic landmarks damaged in the devastating wildfires
2025-09-06 03:44 -
Wegovy trial has doctors encouraged over new possibilities
2025-09-06 02:57 -
Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA
2025-09-06 01:57 -
How to use technology to prevent future drug shortages
2025-09-06 01:56